ATS Labs Announces New Name And Introduces New CEO

EAGAN, Minn., Dec. 8, 2014 /PRNewswire/ -- ATS Labs is happy to announce that it is changing its company name to Accuratus Lab Services.  ATS Labs recently completed a large acquisition of the assets of Microtest Laboratories of Agawam, Massachusetts, enabling it to expand its service offering into the growing medical device and pharmaceutical market segments.  Company Executive Chairman Tom Burnell said, "The new identity and logo had to satisfy all of the existing expectations and strengths associated with the historical ATS Labs and Microtest Laboratories businesses while simultaneously personifying the scientific experience, quality solutions and accurate test results the combined companies provide to the growing medical device, biopharmaceutical and antimicrobial industries."  Accuratus is derived from the Latin word accurate.

Accuratus Lab Services is a leading contract testing lab with over 50 years of quality and expertise in the medical device, pharmaceutical and antimicrobial industries. Accuratus offers a full range of microbiology, virology, analytical chemistry, and clean room testing services. Our ISO certified and FDA/EPA regulated facilities are managed to the strictest standards, and our services are fully compliant with GMP and GLP practices.
The re-branding initiative also involves a change in the organization's domain name and website, with the new website address changing from to  Eric Hess, the newly appointed CEO of Accuratus Lab Services, indicates, "Our current websites and email addresses for ATS Labs and Microtest Laboratories will continue to be operational for the foreseeable future and will not affect the routing of our current emails, nor access to our historical websites."

Eric Hess joined Accuratus Lab Services as Chief Executive Officer in October, 2014.  Eric has had a successful track record of commercial development and will directly lead the sales and marketing initiatives for Accuratus Lab Services, serving as the company's Chief Business Officer, as well.  Supporting Eric will be Alan Roth, who has been serving as the company's Chief Financial Officer. Alan will now also serve as the Chief Operating Officer of Accuratus Lab Services.  In his new role, in addition to the accounting and finance functions, Alan will assume direct responsibility for operations, facilities, IT and risk management.

We look forward to continuing to deliver high quality laboratory services and outstanding customer service and we thank your for your cooperation and continued support.

For more information, visit

Media Contact:


Thomas W. Burnell                       


Executive Chairman                                             


[email protected]                                   



Logo -

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.